COVID-19 Vaccines have good future in treatment of Cancer patients.........

"Covishield, Moderna, and Pfizer vaccines are found effective in the treatment of cancer disease, research revealed"

The effective vaccine to prevent corona is also proving good effect on cancer patients without showing any side effects on the patients. Scientists have presented their research at the conference of the European Society of Medical Oncology. 

According to the researchers, a suitable and protective immune response to the vaccine has been seen in cancer patients. According to the study, the third booster dose of the vaccine may prove to be more effective in cancer patients. Researchers also presented several previous studies and reports published in journals showing the effective effect of Covid -19 on cancer patients.

Vaccine develops effective immunity on cancer patients- Clinical trials of these vaccines were not done on cancer patients, because during the treatment of cancer, the immunity of the patients is already low due to the disease, so there was a fear about whether the vaccine is safe for the patients or not. Clinical trials were not conducted on these patients. An earlier study explored the potential impact of chemotherapy and immunotherapy on the protection provided by vaccination against COVID-19. In the latest study, it has been proved that the vaccine develops effective immunity against Covid in cancer patients.

Sufficient levels of antibodies found in cancer patients- Researchers included several hundred patients from different hospitals in the Netherlands in four different study groups to measure their responses to Moderna's two-dose vaccine. To validate the study, the researchers included non-cancerous individuals, patients treated with immunotherapy, patients treated with chemotherapy, and patients treated with a chemo-immunotherapy combination.

According to the study, after 28 days of giving the second dose, 84 percent of the patients receiving chemotherapy were found to develop sufficient antibodies against the corona. In addition, adequate levels of antibodies were also observed in 89 percent of patients receiving chemo-immunotherapy and 93 percent of patients receiving immunotherapy.